학술논문

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Document Type
Artikel
Source
The Lancet. Neurology. 17(5):405-415
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1474-4465